|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |||
| 化学式 | C29H27NO8 |
||||||
| 分子量 | 517.53 | CAS No. | 530141-72-1 | ||||
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (193.22 mM) | ||||
| Water | Insoluble | ||||||
| Ethanol | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | T-5224 is a selective inhibitor of transcription factor c-Fos/activator protein (AP)-1 with anti-inflammatory effects. T-5224 specifically inhibits the DNA binding activity of c-Fos/c-Jun and the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription. |
|---|---|
| in vitro | T-5224 inhibits matrix-degrading MMPs and inflammatory cytokines including interleukin 1β. This compound reduces the amounts of inflammatory cytokines and MMPs in vitro in synovial cell and chondrocyte cultures.[1] |
| in vivo | T-5224 is an inhibitor of c-Fos/activator protein-1 (AP-1) that prevents type II collagen–induced arthritis by reducing the amounts of inflammatory cytokines, MMPs and anti-tumor necrosis factor α in vivo in sera and joints.[1] |
| 細胞アッセイ | 細胞株 | NIH/3T3, RAW264.7, human synovial sarcoma SW982 and human chondrosarcoma SW1353 cells |
|---|---|---|
| 濃度 | 5.2 μM, 10 μM, 17 μM, 30 μM, 14 μM, 20 μM, 28 μM, 40 μM, 57 μM, 80 μM | |
| 反応時間 | 1 h | |
| 実験の流れ | Reporter assay. NIH/3T3 cells are transiently transfected with the luciferase reporter plasmids pAP-1-Luc(×7 TGACTAA), pNF-kB-Luc(×5 TGGGGACTTTCCGC) or control phRL-TK, and cultured overnight. Cells are incubated in 0.5% FBS/DMEM containing T-5224 for 1 h, and then stimulated with PMA (10 ng/ml) or TNFa (10 ng/ml), and then cultured for 3 h, followed by measurement of lysate by using dual-luciferase reporter assay system. |
|
| 動物実験 | 動物モデル | Male 8-week-old DBA/1J mice |
| 投薬量 | 3 mg/kg | |
| 投与方法 | Oral gavage |
|
| Identifying the Intergenic ALK Fusion LOC388942-ALK as a Driver of Non-Small Cell Lung Cancer [ MedComm (2020), 2025, 6(4):e70154] | PubMed: 40151836 |
| Identifying the Intergenic ALK Fusion LOC388942-ALK as a Driver of Non-Small Cell Lung Cancer [ MedComm (2020), 2025, 6(4):e70154] | PubMed: 40151836 |
| c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment [ Cells, 2025, 14(7)474] | PubMed: 40214428 |
| Injured tubular epithelia-derived CCN1 promotes the mobilization of fibroblasts toward injury sites after kidney injury [ iScience, 2025, 28(4):112176] | PubMed: 40224016 |
| Risk Allele rs117026326-Mediated Alternative Splicing of GTF2I Promotes B Cell Proliferation in Primary Sjögren's Syndrome [ J Immunol Res, 2025, 2025:4821639] | PubMed: 40007754 |
| SLPI as a dedifferentiation biomarker in BRAFV600E-mutant papillary thyroid cancer [ Endocr Connect, 2025, 14(8)e250349] | PubMed: 40742326 |
| Persistent Activation of Endothelial Cells is Linked to Thrombosis and Inflammation in Cerebral Cavernous Malformation Disease [ bioRxiv, 2025, 2025.06.29.662238] | PubMed: 40631268 |
| Dynamic regulation of tissue fluidity controls skin repair during wound healing [ Cell, 2024, S0092-8674(24)00825-0] | PubMed: 39168124 |
| Collagen signaling and matrix stiffness regulate multipotency in glandular epithelial stem cells in mice [ Nat Commun, 2024, 15(1):10482] | PubMed: 39695111 |
| Positive and negative feedback regulation of the TGF-β1 explains two equilibrium states in skin aging [ iScience, 2024, 27(5):109708] | PubMed: 38706856 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。